 Principia Biopharma NASDAQ:PRNB was downgraded by BidaskClub from a buy rating to a hold rating in a research note issued to investors on Wednesday, BidAskClub reports. Other equities research analysts have also issued research reports about the stock. ValuEngine upgraded shares of Principia Biopharma from a sell rating to a hold rating in a report ... 